Targeted Drug Delivery | 5th Joint Meeting of GBM & BioPharma Cluster South German

Targeted Drug Delivery | 5th Joint Meeting of GBM & BioPharma Cluster South German
Go back

27.11.2026 | Ulm 

5th Joint Meeting

BioPharma Cluster South Germany
& Gesellschaft für Biochemie und
Molekularbiologie

Das 5. Netzwerk-Meeting, das der BioPharma Cluster South Germany zusammen mit der Gesellschaft für Biochemie und Molekularbiologie (GBM) ausrichtet, verfolgt auch 2026 das Ziel, die Lücke zwischen akademischer Forschung und industrieller Umsetzung zu schließen.

Die fünfte Auflage der englischsprachigen Veranstaltung widmet sich der zielgerichteten Wirkstoffverabreichung, der „Targeted Drug Delivery“.

Dieses Forschungs-, Entwicklungs- und Anwendungsgebiet gewinnt zunehmend an Bedeutung, da es die gezielte Verabreichung von Wirkstoffen direkt an ihren Wirkort ermöglicht. Dadurch kann die therapeutische Wirksamkeit maximiert und gleichzeitig das Risiko systemischer Nebenwirkungen minimiert werden.

Programm und Registrierung finden sich hier.

register now

Our latest News

discover more
13.2 million euros for new immunotherapies against Ewing sarcomas in children and adolescents

13.2 million euros for new immunotherapies against Ewing sarcomas in children and adolescents

The European research project THEODORA is launching during “Gold September”, the international childhood cancer awareness month. Researchers at the Heidelberg Medical Faculty of Heidelberg University, drawing on their expertise in clinical research and precision oncology at Hopp Children’s Cancer Center Heidelberg (KiTZ), are collaborating with Institut Curie in Paris, Prinses Máxima Centrum in Utrecht, and […]

read more
Light-Based 3D Printing: Innovative “Ink” Enables a Closed-Loop Material Cycle

Light-Based 3D Printing: Innovative “Ink” Enables a Closed-Loop Material Cycle

Heidelberg research team develops a polymer material that can be broken down into its individual components and reused Polymers used for light-based 3D printing are very stable due to their chemical structure, but they are typically hard to recycle. A research team led by Prof. Dr. Eva Blasco, a researcher at the Institute for Molecular […]

read more
Colon Cancer: How Highly Aggressive Tumors Evade the Immune System

Colon Cancer: How Highly Aggressive Tumors Evade the Immune System

Researchers from the German Cancer Research Center (DKFZ) and the HI-STEM* Stem Cell Institute have identified a previously unknown mechanism by which a particularly aggressive form of colon cancer evades the immune system. The findings show that the activation of a key signaling pathway helps cancer cells suppress the immune system, thereby promoting the development […]

read more

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp